Back to Search
RICHARD PARAD, MD
Neonatal-Perinatal Medicine Physician
NPI: 1689656753IndividualAccepts Medicare
Specialties, Licenses & Credentials
Pediatrics Physician
Pediatrics
Code: 208000000X
53655(MA)
Neonatal-Perinatal Medicine PhysicianPrimary
Pediatrics — Neonatal-Perinatal Medicine
Code: 2080N0001X
53655(MA)
Education
UNIVERSITY OF CALIFORNIA, SAN DIEGO SCHOOL OF MEDICINE
Class of 1981
Research & Publications (20)
Diagnostic dilemmas resulting from the immunoreactive trypsinogen/DNA cystic fibrosis newborn screening algorithm.
PMID 16202789·J Pediatr·2005
4-observational
Sweat testing infants detected by cystic fibrosis newborn screening.
PMID 16202787·J Pediatr·2005
4-observational
Oropharyngeal flora in healthy infants: observations and implications for cystic fibrosis care.
PMID 19360845·Pediatr Pulmonol·2009
8-other
Endotoxin-directed innate immunity in tracheal aspirates of mechanically ventilated human neonates.
PMID 19390484·Pediatr Res·2009
7-preclinical
Economic evaluation of recombinant human copper zinc superoxide dismutase administered at birth to premature infants.
PMID 19225525·J Perinatol·2009
8-other
Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report.
PMID 18639722·J Pediatr·2008
6-review
Newborn screening showing decreasing incidence of cystic fibrosis.
PMID 18305279·N Engl J Med·2008
8-other
Guidelines for implementation of cystic fibrosis newborn screening programs: Cystic Fibrosis Foundation workshop report.
PMID 17272609·Pediatrics·2007
6-review
Early pulmonary manifestation of cystic fibrosis in children with the DeltaF508/R117H-7T genotype.
PMID 16951024·Pediatrics·2006
5-case
Challenges in implementing a successful newborn cystic fibrosis screening program.
PMID 16202791·J Pediatr·2005
6-review
Communications systems and their models: Massachusetts parent compliance with recommended specialty care after positive cystic fibrosis newborn screening result.
PMID 16202793·J Pediatr·2005
4-observational
Balancing benefits and risks for cystic fibrosis newborn screening: implications for policy decisions.
PMID 16202773·J Pediatr·2005
6-review
Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections.
PMID 15173476·Pediatrics·2004
8-other
Pulmonary outcome at 1 year corrected age in premature infants treated at birth with recombinant human CuZn superoxide dismutase.
PMID 12612223·Pediatrics·2003
3-trial
A three-center, randomized, controlled trial of individualized developmental care for very low birth weight preterm infants: medical, neurodevelopmental, parenting, and caregiving effects.
PMID 14671473·J Dev Behav Pediatr·2003
3-trial
Urine bombesin-like peptide elevation precedes clinical evidence of bronchopulmonary dysplasia.
PMID 11956050·Am J Respir Crit Care Med·2002
8-other
Antenatal glucocorticoid treatment does not reduce chronic lung disease among surviving preterm infants.
PMID 11233077·J Pediatr·2001
8-other
Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? The Neonatology Committee for the Developmental Network.
PMID 10835057·Pediatrics·2000
4-observational
Long-term follow-up of premature infants treated with prophylactic, intratracheal recombinant human CuZn superoxide dismutase.
PMID 10879331·J Perinatol·2000
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 75 FRANCIS ST CWN 418, BRIGHAM & WOMEN'S HOSPITAL
BOSTON, MA 02115 - Phone
- (617) 732-7371
Quick Facts
- NPI
- 1689656753
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile